Ovarian cancerNicoletta Colombo, Ignace Vergote, Gemma Gatta et al.|Critical Reviews in Oncology/Hematology|2006Cited by 218
Phase III MIRASOL (GOG 3045/ENGOT-ov55) study: Initial report of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in platinum-resistant, advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression.Kathleen N. Moore, Toon Van Gorp, Antoine Angelergues et al.|Journal of Clinical Oncology|2023Cited by 53